-
2022 - 01 - 17
Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant
-
2022 - 02 - 02
Conversations with Nobel Prize Winners: The Fondazione Menarini launches their “Dialogs Beyond Borders” series
-
2022 - 03 - 14
MENARINI DIAGNOSTICS DETECTS ALL COVID VARIANTS
-
2022 - 05 - 08
Raffaello, maestro di armonia e difensore dei beni culturali protagonista del volume d’arte di Menarini
-
2022 - 05 - 09
Berlin-Chemie Menarini’s position in Ukraine
-
2022 - 05 - 20
Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology
-
2022 - 05 - 20
Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO<sup>®</sup> (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma
-
2022 - 05 - 26
Menarini inaugurates new regional headquarters in Dubai, UAE
-
2022 - 06 - 06
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
-
2022 - 06 - 07
Premio Internazionale Fair Play Menarini, assegnato il Premio speciale Fiamme Gialle “Studio e sport”
-
2022 - 06 - 22
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
-
2022 - 06 - 23
The XXVI Fair Play Menarini International Award opens with a press conference at CONI
-
2022 - 06 - 28
NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe
-
2022 - 06 - 30
Il Premio Internazionale Fair Play Menarini arriva a Firenze, presentata la XXVI edizione a Palazzo Vecchio
-
2022 - 07 - 04
Il XXVI Premio Internazionale Fair Play Menarini debutta a Firenze, “I campioni si raccontano” in diretta tv dal Salone dei Cinquecento
-
2022 - 07 - 06
Premio Internazionale Fair Play Menarini: dopo “I campioni si raccontano” la cena di gala in attesa della cerimonia di premiazione
-
2022 - 07 - 07
Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award
-
2022 - 07 - 21
Karyopharm and Menarini Receive Full Marketing Authorisation from the European Commission for NEXPOVIO<sup>®</sup> (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
-
2022 - 08 - 02
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination
-
2022 - 08 - 04
ATGC Co., Ltd. License Agreement Grants RELIFE S.r.l. Exclusive Rights to Register, Promote, Distribute, and Market the Novel Botulinum Toxin Type A (ATGC-100) in Europe and the United Kingdom.
-
2022 - 08 - 11
Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer
-
2022 - 08 - 19
Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer
-
2022 - 09 - 08
Nasce ON RADAR il laboratorio di pensieri, idee, dialogo
-
2022 - 10 - 14
Giorgione: Maestro di mistero, tra Rinascimento e modernità. Domani a Venezia la presentazione del volume d'arte di Menarini dedicato all'artista
-
2022 - 11 - 01
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis
-
2022 - 11 - 02
QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform
-
2022 - 11 - 24
Le Volpi Rosse Menarini continuano la loro avventura in Serie A
-
2022 - 11 - 29
Lost childhood: a 'tight-knit' network to combat abuse and distress
-
2022 - 11 - 30
Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS)
-
2022 - 12 - 14
Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH<sup>®</sup> System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early
-
2022 - 12 - 19
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination